Gregg Fonarow

Dr. Gregg Fonarow, Professor of Medicine and Interim Chief of UCLA’s Division of Cardiology, discusses the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Topics include the management of heart failure in patients with renal insufficiency and the use of hydralazine-nitrate combination therapy. The combination helps attenuate tolerance commonly seen with nitrates and preserves arterial and venous dilation. However, mortality outcomes differ, particularly in African American patients, emphasizing the need for long-term renal and cardiovascular protection.